chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a healthcare professional (nurse practitioner) and described the occurrence of rash aggravated in a 42-year-old female subject who was vaccinated with BOOSTRIX, (GlaxoSmithKline). Concurrent medical conditions included puncture wound and rash. The subject was administered BOOSTRIX on 12 August 2013 after coming into the office with a puncture wound and rash. Historic vaccination included Td vaccine; manufacturer unspecified; unknown; unknown given in 1999. On 12 August 2013 the subject received a dose of BOOSTRIX (unknown details). On 14 August 2013, 2 days after vaccination with BOOSTRIX, the subject experienced rash aggravated (described as "worsening rash"). The subject was possibly treated with prednisone. The nurse practitioner wanted to prescribed prednisone for the subject. At the time of reporting the event was worse.
Tinnitus, ringing in the ears; Onset within 45 minutes of vaccine jab;
Patient was given an adult dose of Pfizer. Patient is the size of an adult. Patient and parent made aware of the dose mix-up. Parent notified of the improper dose given. Patient and family stayed and was able to be observed for 15-30min. Patient showed no signs and symptoms of an adverse reaction and stated that he was fine and had no issues. Writer will follow-up with patient on the next business day.
6-22-07 Mom called in with questions and reports that child has developed "spots" (*5) over his trunk and low grade fever giving Ibuprofen for discomfort - reassurance of support offered. To seek MD if condition worsens.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medication was reported.  190 patients (9 different lot numbers) received a vaccine past the beyond used by date.  It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No treatment medication was reported.  This case pertains to the 73th patient of the total 190 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced unspecified adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified adverse event was not reported. This report was non-serious.
vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided. Treatment provided was unknown.   Reporter did not allow further contact
Site: Pain at Injection Site-Medium, Additional Details: Patient states her received both vaccinations in the right arm on the same day (02/19/20) and that he has had pain in the muscle since receiving. States NO redness or bruising. Has difficulty lifting arm above his head. Pain is still present
Exactly 1 week of getting her second round of the HepA vaccine she began to have a strange bruising like rash begin on 09-07-2017 we took her to the Emergency Room where she was misdiagnosed. 2 days later her face and eyes began to swell along with her hands, ankles, and knees. The rash/bruising continued to get worse. 09-09-2017 she was diagnosed with HSP or Henoch-Schonlein Purpura. We have gone to the ER 4 times, urgent care, her PCP, and 2 specialists (blood and kidney). Just about all of the doctors seen have told us the HepA vaccine very likely triggered the HSP because she was perfectly healthy before getting the shot. In the past 19 days my 3 year old has gone through pure hell. Several breakouts a day, large bruising all over her body, lots of swelling, itching, pain in her joints on a daily basis that have been crippling at times, pain in her stomach and back.
Seizure; Vaccination adverse reaction; This spontaneous case was reported by a physician and describes the occurrence of SEIZURE (Seizure) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEIZURE (Seizure) (seriousness criterion medically significant) and VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, SEIZURE (Seizure) and VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not provided. Treatment medication were not reported.  Company Comment: Very limited information regarding these events has been provided at this time. No further information is expected at this time.; Sender's Comments: Very limited information regarding these events has been provided at this time. No further information is expected at this time.
pt still in house  Active Hospital Problems   Diagnosis   ? (Principal) COVID-19 DISEASE   ? ELEVATED TSH   ? VASCULAR PARKINSONISM   ? BPH (BENIGN PROSTATIC HYPERPLASIA)   ? HYPERLIPIDEMIA   ? HTN (HYPERTENSION)
He presented to the ED with generalized weakness with mulitple falls at home.                                      Covid vaccines 03/22/2021 02/17/2021
Clients mthr TC to this nrsg supervisor at 2:05 pm on 7/16/13 to report: "Client developed fever but she did not have a thermometer to take his temp, but he felt very hot, as well as developed pink 1/2" rash (L) arm. Mother gave client Ibuprofen with some improvement. Onset sympt at 8 pm on 7/15/13".
Myalgia, Fever,  CHILLS, FEVER, FATIGUE, BODY ACHES, itching at inj site  Narrative:  Other Relevant History:
Within 4-5 hours, patient became nauseated, vomited, had a fever of 101.8 degrees. Ended up at our hospital ER.
Narrative:  As per 10/13/21 ED Note HPI: Patient is a 81-year-old male who presents to the emergency department as a transfer from the hospital with chief complaint of decreased p.o. intake, failure to thrive, 25 pound weight loss, generalized weakness. Patient on 9/10/2021 underwent vascular procedure on his legs at clinic and was discharged from the hospital at 9/17/2021 to rehab. He was then discharged from rehab on 10/1/2021. He was discharged home with his spouse. Patient apparently has not been eating over the past for some time. He has also decreased fluid intake. At the hospital, patient was tested for Covid and this resulted as positive. It was initially reported the patient was hypotensive at 92/62 with a heart rate of 115 but was afebrile. Upon arrival, patient was normotensive at 140/62 with a heart rate of 96. No known exacerbating or remitting factors. Patient is a 81-year-old male presenting to the hospital with complaints of significant weight loss and failure to thrive with positive COVID-19 test. Case was discussed with the admitting physician and patient treatment plan as below. COVID-19 infection -Patient is currently not requiring supplemental oxygen and does not qualify for remdesivir therapy or dexamethasone -Patient is not in respiratory distress and will be monitored while inpatient. -Patient will need placement as he is unable to care for himself at home and his wife is unable to supplement his care -Continue to monitor for exacerbation of the patient's condition with nasal pulse ox time cardiac monitor Failure to thrive -Patient reports significant weight loss even while being in an institution for rehabilitation -Patient will have supplemental protein replacement at each meal -Patient have a heart healthy diet -At this time prealbumin will be obtained -Patient is high risk to return home and current living conditions and medical therapy requirements according to the patient should return to rehabilitation in the short-term
Pt claims reaction to Anthrax #5, nausea, cough, weakness, dizziness, fever, shortness of breath X 1 day, headache, with sore throat. 10 days, post vax, dx of AGE. Pt had another Anthrax on 6/6/00, with no problems. Again, pt requested Vaers form.
temp up to 104 R on 21OCT92 evening; pt also was intermittently lethargic & was irritable;
Seen in office today noted to have (R) deltoid swelling red, warm to touch indurated, received KINRIX in (R) arm 6/29/2015 (L) deltoid 5x3 cm, red mild warm non tender received PROQUAD in (L).
Pt arrived for their second dose COV 19 Vaccine on 04/13/2021. Pt's first dose was Moderna Lot #04421A. The pt was incorrectly administered a Pfizer vaccine. No adverse s/s were noted. Following the incident it was discovered that the pt's health form had the incorrect first dose information. The pt was notified appropriately and all questions were answered.
After vaccine injection today patient developed sluggish responses, unsteady gait, metaAllic taste, and "heavy head". Responses were delayed. Reports she was hospitalized in 2019 related to a flu vaccine reaction. Also reports she had an anaphylactic reaction to an allergy injection previously. Taken to exam room and assessed by  CRNP. After 30 minutes patient complained of tingling in her lips and hives around her nose and mouth. Hives noted right side of nose and right side of mouth. Denies any increase sob. Initial vs 133/80, 88 O2sat100%. After 30 minutes vs 124/80 85 and O2sat 93%. Continued to deny increase sob. Reported her head was no longer "heavy". On advice of Provider, Patient was sent to ER for further evaluation.
Agitation, Headache, Sedation, UrticariaPruritus & NauseaVomiting Narrative:
Approx 1 1/2 to 2 hrs post vax pt began screaming & cont non-stop for 5 to 6 hrs; mom tried to feed pt but only sucked a little then screamed again; mom called MD @ 4PM who advised an ER visit if pt did not stop crying in 1 hr;
flu like symptoms; This is a spontaneous report from a contactable consumer (Patient) via Medical information team. A female patient of an unspecified age received received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date the patient experienced flu like symptoms. It was reported that 12 hours after receiving her first dosage of the Covid vaccine, she experienced flu like symptoms. The outcome of event was unknown.  Information on lot/batch number has been requested
I had a sore scratchy throat, so then I kinda had some achy body swollen glands, fatigue and headache and my joints started hurting including my knee. I started getting nasal drainage down my throat. Today my symptoms are about the same. No fever or cough. My symptoms are mild.
The patient has a history of dementia. She arrived to the ED on 8/5/23 by EMS from memory care. At baseline, the patient is usually up walking and talking, however that morning she did not want to get out of bed. The patient was also found to have a temperature of 101.5. O2 sats per EMS were at 86% on room air, so 2L O2 via nasal cannula was provided. In the ED, a COVID PCR test resulted positive. Ultimately, she was admitted 8/5/23-8/7/23. Discharge diagnoses include COVID viral infection with hypoxemia and SIRS due to COVID-19 infection, among other diagnoses. During admission, the patient was treated with oxygen supplements via nasal cannula, dexamethasone, inhalers as needed, incentive spirometer, and pulmonary toileting. She was able to be weaned off supplemental oxygen.  Of note, the patient has received the primary COVID vaccine series and two boosters.
Patient called and reported swelling of the left arm where injection was given, reports was initially red at the site of injection then next day got larger in size. Advised patient to see primary care provider/walk in clinic
11am-screened for flu shot-stated she was immune-compromised and on a lot of med. for rheumatoid arhtirits. Metronidazole, Prednisone-denies egg allergy. Flu shot given. 11:05-negative for problems 11:10 c/o tongue feeling weird and difficulty breathing BP 160/90 P-112 called fire depart-911.  11:05 Epinephrine 0.3 mg sc (R) deltoid adm. by nurse EMT's on site. Family notified. Pt responding and Transported to hospital
Petechiae rash on my abdomen and the front of my upper thighs; This is a spontaneous report from a contactable consumer reported for herself that. A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 20Jan2021 14:30 (Batch/Lot Number: EL3247) as DOSE 1 SINGLE for covid-19 immunizations (Age at vaccination 73 years). The patient past Medical history included known allergies: Sulfa, Dodecyl Gallate, Methyl Methacrylate, Methyl chloroisothiazolinone, Methylisothiazolinone. Concomitant medication(s) included ergocalciferol (VIT D) taken for an unspecified indication, cyanocobalamin (VIT B12) taken for an unspecified indication and acetylsalicylic acid (ASPIRIN) taken for an unspecified indication. The patient previously took Relafen and Amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 25Jan2021, 5 Days after the first dose, the patient developed a Petechiae rash on her abdomen and the front of her upper thighs. This remained inflamed for about 3 days and began to subside and was clear after about a week. On the 10th day after the 2nd dose, she developed the Petechiae again and this time it was much more and became more intense over 3-4 days and was on her upper thighs in front and inner thighs and to her knees, especially heavy behind her knees and then about halfway down her calf and was lighter on her abdomen than after the first dose. The rash appeared to clear about another 5 days, then began to intensify again, and only began to noticeably clear around day 28. It is now day 30 and is almost clear though the skin feels a little "hot" in the most intense areas. The event outcome was recovering.  No follow-up attempts are possible. No further information is expected.
Patient received Pfizer COVID vaccine on 6/18/21 and 7/16/21. On 1/25/22, patient tested positive for COVID-19. On 1/27/22, patient admitted to our inpatient facility with acute on chronic systolic congestive heart failure causing respiratory insufficiency, chronic atrial fibrillation on warfarin with supratherapeutic INR, acute kidney injury on CKD, and COVID-19 infection mildly symptomatic. As of today (1/28/22), patient is still admitted in the med/surgical unit.
Eye inflamed/ Inflammed blood vessels around right eye.; This spontaneous case was reported by a consumer and describes the occurrence of EYE INFLAMMATION (Eye inflamed/ Inflammed blood vessels around right eye.) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Daily dose: Citrate free. On 09-Dec-2021, the patient experienced EYE INFLAMMATION (Eye inflamed/ Inflammed blood vessels around right eye.). At the time of the report, EYE INFLAMMATION (Eye inflamed/ Inflammed blood vessels around right eye.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Drugs were not reported.  The reporter's causality for the event of inflammed blood vessels around right eye with Moderna vaccine was Probable.  The reporter's causality for the event of inflammed blood vessels around right eye with HUMIRA(Adalimumab)was no reasonable possibility.  No treatment information was provided by the reporter.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
patient did not remember states he forgets sometimes; Initial information regarding an unsolicited valid non-serious case was received from a consumer/non-health care professional (patient) via Medical Information (Reference number- 00661430) and transmitted to Sanofi on 29-Jun-2021.  This case involves a 24 year old male patient who said that he did not remember states, he forgets sometimes (Memory impairment) after receiving INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  Relevant medical history, medical treatment(s), vaccination(s) concomitant medication and family history were not provided.   On an unknown date in last year the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination  On an unknown date the patient developed a non-serious patient did not remember states he forgets sometimes (memory impairment) (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Additionally it was reported as Caller wants to know the side effects of tenivac and does it cause cancer or male infertility? Also wants to know about flublok hat he took last year and if it causes cancer or male infertility? Caller hasn't taken Tenivac and was given the name by the pharmacy he may get the vaccine from but has taken Flublok last year. Caller mentions he is not attempting to conceive nor has he had any symptoms but just asking the question. Caller feels testing should be done on all the vaccines for male infertility. Additional Description of event Adverse events :Caller mentions during the conversation that he didn't remember providing his email and states he forgets sometimes. Caller didn't mention any side effects of the Flublok and isn't trying to conceive. Caller mentions having the CoVid (corona virus disease) vaccine but didn't say which one.  No relevant laboratory data was provided.  It was not reported if the patient received a corrective treatment for the event  At time of reporting, the outcome was unknown for the event  There will be no information available on the batch number for this case.
Pt was fussy with crying for 3 hours starting at bedtime. She continued to have redness and swelling approx 1 1/2" x 2" in diameter in left lateral aspect of leg. Fever was no higher than 100.2 deg. F. The nurse instructed parent to continue using anti-inflammatory every 6-8 hours with Motrin and start using warm and cold compression on left leg.
Information regarding Flumist (2003-2004 Formula)(influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a consumer reporting that she experienced "flu" subsequent to receiving Flumist on an unspecified date. Relevant medical history was not provided.  Indication for Flumist (2003-2004 Formula) was immunization.  Product was administered on an unspecified date. Dose regimen was not provided.  Concomitant medications were not reported.  The pt reported that she experienced "flu" subsequent to receiving Flumist on an unspecified date.  She recovered.  No additional information was available at the time of this report.
Next day muscles sore and swollen at site of injection. Today red at site injection and itchy. Putting antibiotic cream on it, took BENADRYL. Spoke to nurse. Similar to latex allergy reaction which usually takes 3 days.